Real-world study of cabozantinib treatment of advanced renal cell carcinoma in Taiwan
{{output}}
Background: There is a lack of real-world evidence from Taiwan on the use of cabozantinib for advanced renal cell carcinoma (aRCC). We evaluated cabozantinib treatment for aRCC after previous antiangiogenic therapy in real-world ... ...